1 employees
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.
2011
$24M
from 3 investors over 3 rounds
Armetheon, Inc. raised $24M on February 5, 2015
Investors: Atheneos Ventures and CDIB Capital International Corporation
Armetheon, Inc. raised $7M on August 28, 2014
Investors: Atheneos Ventures